Start-up Spotlight: Enzyre Creates Portable Device For Monitoring Blood Coagulation
Seed investor Novalis Biotechnology Incubator sees Enzyre’s technology as an opportunity to get testing closer to patients.
You may also be interested in...
The Dutch company received the US FDA's breakthrough device designation in 2018 for the surgical patch.
Johnson & Johnson previously agreed to acquire TachoSil but terminated the transaction due to regulatory hurdles.
Emmanuel Ligner, president and CEO of Cytiva, talks to In Vivo about how the company will dramatically increase its manufacturing capabilities over the next five years, at a price tag of $500m.